Clinical Trial Detail

NCT ID NCT03957096
Title A Safety Study of SGN-CD47M in Patients With Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications

pancreatic adenocarcinoma

colorectal carcinoma

melanoma

breast carcinoma

lung non-small cell carcinoma

ovarian carcinoma

head and neck squamous cell carcinoma

stomach carcinoma

sarcoma

Therapies

SGN-CD47M

Age Groups: adult senior

No variant requirements are available.